Pages that link to "Q34221541"
Jump to navigation
Jump to search
The following pages link to Glutamatergic influences on the basal ganglia. (Q34221541):
Displaying 28 items.
- Up-regulation in expression of vesicular glutamate transporter 3 in substantia nigra but not in striatum of 6-hydroxydopamine-lesioned rats (Q28572359) (← links)
- Enhanced sensitivity to group II mGlu receptor activation at corticostriatal synapses in mice lacking the familial parkinsonism-linked genes PINK1 or Parkin. (Q30492449) (← links)
- Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy--implications for excitotoxicity (Q33754643) (← links)
- Opposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosis (Q34807095) (← links)
- Metabolic modulation of potassium channels (Q35776780) (← links)
- GABA and glutamate systems as therapeutic targets in depression and mood disorders (Q36066308) (← links)
- Activation of ATP-sensitive K+ (K(ATP)) channels by H2O2 underlies glutamate-dependent inhibition of striatal dopamine release (Q36161572) (← links)
- Neuroprotection by rasagiline: a new therapeutic approach to Parkinson's disease? (Q36188726) (← links)
- Metabotropic glutamate receptor 4 in the basal ganglia of parkinsonian monkeys: ultrastructural localization and electrophysiological effects of activation in the striatopallidal complex (Q36374309) (← links)
- Pharmacokinetic optimisation in the treatment of Parkinson's disease : an update. (Q36399714) (← links)
- T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening? (Q37625319) (← links)
- Association of Parkinson disease age of onset with DRD2, DRD3 and GRIN2B polymorphisms (Q40251864) (← links)
- Downregulation of glial glutamate transporters after dopamine denervation in the striatum of 6-hydroxydopamine-lesioned rats. (Q42442641) (← links)
- Spare respiratory capacity rather than oxidative stress regulates glutamate excitotoxicity after partial respiratory inhibition of mitochondrial complex I with rotenone. (Q42515219) (← links)
- Lesion of substantia nigra pars compacta by the GluR5 agonist ATPA. (Q42527640) (← links)
- Ketamine-induced oscillations in the motor circuit of the rat basal ganglia (Q42847462) (← links)
- Effects of depressive-like behavior of rats on brain glutamate uptake. (Q43092657) (← links)
- Treatment with 1,2,3,4,-tetrahydroisoquinoline affects glutamate release in the striatum but not the binding of [3H]MK-801 to NMDA receptors in the dopaminergic structures of the rat brain (Q43244749) (← links)
- NMDA receptor antagonists ameliorate the stepping deficits produced by unilateral medial forebrain bundle injections of 6-OHDA in rats (Q44790993) (← links)
- Distinct mechanisms of presynaptic inhibition at GABAergic synapses of the rat substantia nigra pars compacta (Q46535378) (← links)
- Dopamine depletion does not protect against acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in vivo. (Q46750122) (← links)
- Motor complications in Parkinson's disease: Striatal molecular and electrophysiological mechanisms of dyskinesias (Q47344907) (← links)
- Brain glutamate in medication-free depressed patients: a proton MRS study at 7 Tesla (Q47682835) (← links)
- Genetic variants of the NMDA receptor influence cortical excitability and plasticity in humans (Q49052293) (← links)
- Targeting metabotropic glutamate receptors as a new strategy against levodopa-induced dyskinesia in Parkinson's disease? (Q51750611) (← links)
- Metabotropic Glutamate Receptor 5 and 8 Modulate the Ameliorative Effect of Ultramicronized Palmitoylethanolamide on Cognitive Decline Associated with Neuropathic Pain (Q64064014) (← links)
- The Modulation of Pain by Metabotropic Glutamate Receptors 7 and 8 in the Dorsal Striatum (Q64760299) (← links)
- Excitotoxicity (Q82029465) (← links)